China bans more synthetic opioids blamed for US drug deaths

June 19, 2017 by Louise Watt
Deng Ming, deputy director of the National Narcotics Control Commission speaks during the National Anti-drug Committee briefing at a hotel in Beijing, Monday, June 19, 2017. China has announced it is banning a deadly synthetic opioid called U-47700 and three other synthetic drugs. Deng said the drugs would be added to China's list of controlled substances as of July 1. (AP Photo/Andy Wong)

China said Monday it would ban a designer drug called U-47700 and three others, following U.S. pressure to do more to control synthetic opioids blamed for fast-rising overdose deaths in the United States.

In China, U-47700 has until now been a legal alternative to fentanyl and potent derivatives like carfentanil. Its usage has been growing among U.S. opioid addicts.

Last year, the U.S. Drug Enforcement Administration listed U-47700 in the category of the most dangerous drugs it regulates, saying it was associated with dozens of fatalities, mostly in New York and North Carolina. Some of the pills taken from Prince's estate after the musician's overdose death last year contained U-47700.

The DEA has long said that China is the top source country for synthetic opioids like fentanyl and its precursors, assertions Beijing has said lack firm evidence. Still, the two countries have deepened cooperation as the U.S. opioid epidemic intensifies.

Deng Ming, deputy director of the National Narcotics Control Commission, said that U-47700 and three other synthetic drugs—MT-45, PMMA, and 4,4'-DMAR—would be added to China's list of controlled substances as of July 1.

Yu Haibin, a division director at the Ministry of Public Security's Narcotics Control Bureau, said China was making "big efforts" to deal with drugs known as new psychoactive substances. These substances are made by modifying the chemical structures of controlled substances in order to get around the law, and China has now restricted 138 of them.

Deng Ming, deputy director of the National Narcotics Control Commission listens a question by Justin Schoeman from U.S. drug enforcement administration base in Beijing, during the National Anti-drug Committee briefing at a hotel in Beijing, Monday, June 19, 2017. China has announced it is banning a deadly synthetic opioid called U-47700 and three other synthetic drugs. Deng said the drugs would be added to China's list of controlled substances as of July 1. (AP Photo/Andy Wong)

However, as soon as one substance is banned, chemists create slightly different and technically legal alternatives and then market them online.

"My feeling is that it's just like a race and I will never catch up with the criminals," Yu told a news conference. "Actually, we just want to make a breakthrough in dealing with this."

To counter the cat-and-mouse game, Yu said authorities had set up a system whereby information on new types of drugs gleaned during police investigations, customs clearances and medical treatment would be transferred to the national drug lab. An expert committee would then assess this information and send alert notices to relevant agencies in order to help speed up the control of new substances, he said.

Yu said suspects use the internet to communicate with customers and use the anonymized digital currency bitcoin to transfer money, and that authorities were working with internet companies to try to stop such trade and the advertising of drugs on websites.

To combat drugs being sent by post or express delivery service, authorities were carrying out real-name registration requirements and X-rays of parcels being delivered to "high-risk areas," he said.

Deng Ming, deputy director of the National Narcotics Control Commission speaks during the National Anti-drug Committee briefing at a hotel in Beijing, Monday, June 19, 2017. China has announced it is banning a deadly synthetic opioid called U-47700 and three other synthetic drugs. Deng said the drugs would be added to China's list of controlled substances as of July 1. (AP Photo/Andy Wong)

Addressing the news conference, Justin Schoeman, Beijing-based country attache for the U.S. Drug Enforcement Administration, said: "I can tell you that when China controls a substance, (new psychoactive substances) or fentanyl-classed substance, it has a huge impact on seizures and availability in the U.S., so thank you very much.

"The controlling of substances in China certainly saves lives in the U.S.," he added.

He added that China's banning of additional substances means the U.S. and China can now carry out joint investigations on those chemicals, including the tracking of packages from the source through to the recipients in the U.S.

U-47700 is a synthetic opioid, a fast-proliferating class of drugs that have caused thousands of deaths in the United States. In 2015 alone, there were 9,580 deaths due to synthetic opioids other than methadone, accounting for almost a fifth of all drug overdose deaths.

Explore further: The latest opioid street mix causing concern: 'Gray death'

Related Stories

The latest opioid street mix causing concern: 'Gray death'

May 4, 2017
It's being called "gray death"—a new and dangerous opioid combo that underscores the ever-changing nature of the U.S. addiction crisis.

Five things to know about America's synthetic-opioid epidemic

December 21, 2016
Government scientists say they're seeing the emergence of a new class of deadly drugs built to mimic the potent prescription painkiller fentanyl. What you need to know:

China carfentanil ban a 'game-changer' for opioid epidemic

February 16, 2017
So deadly it's considered a terrorist threat, carfentanil has been legal in China— until now. Beijing is banning carfentanil and three similar drugs as of March 1, China's Ministry of Public Security said Thursday, closing ...

New synthetic drug U-47700 has states rushing to stop spread

June 7, 2016
A new synthetic drug that can be purchased online and is connected to at least 50 deaths nationwide has several states scrambling to stop its spread, with Kansas law enforcement agencies seeking an emergency ban.

Street Norco looks like the real thing but really, really isn't

July 28, 2016
A paper published online yesterday in Annals of Emergency Medicine warns that a new street drug combining fentanyl and a novel synthetic opioid is being marketed illicitly as Norco but is much stronger and much more dangerous.

Painkiller that killed Prince part of dangerous wave of new synthetic drugs

June 16, 2016
(HealthDay)—The recent overdose death of rock legend Prince has brought renewed focus on the dangers posed by synthetic opioids—laboratory-created narcotics tweaked by chemists to produce potentially lethal highs while ...

Recommended for you

With no morphine, 25 million die in pain each year: report

October 13, 2017
Every year, some 25 million people—one in ten of them children—die in serious pain that could have been alleviated with morphine at just a few cents per dose, researchers said Friday.

Study finds few restrictions on Rx opioids through Medicare

October 9, 2017
Medicare plans place few restrictions on the coverage of prescription opioids, despite federal guidelines recommending such restrictions, a new Yale study finds. The research results highlight an untapped opportunity for ...

Nocebo effect: Does a drug's high price tag cause its own side effects?

October 5, 2017
Pricey drugs may make people more vulnerable to perceiving side effects, a new study suggests—and the phenomenon is not just "in their heads."

Pre-packaged brand version of compounded medication to prevent preterm births costs 5,000 percent more

October 2, 2017
Preventing a preterm birth could cost as little as $200 or as much as $20,000, depending on which one of two medications a doctor orders, according to a new analysis from Harvard Medical School.

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.